Get the app!
Back to Trades

Prener Anne

DirectorCIK 0001797917

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
3
Companies
1
Active
2026

Prener Anne, Director, has filed 4 SEC reports (2026), all concentrated in Keros Therapeutics, Inc. (KROS), totaling $173.6K in disclosed volume. Weighing $0 bought versus $11.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Nov 19KROS
Keros Therapeutics, Inc.
Prener AnneDirectorSell$6.2K
Nov 16KROS
Keros Therapeutics, Inc.
Prener AnneInsiderSell$5.6K
Jul 6KROS
Keros Therapeutics, Inc.
Prener AnneInsiderGrant$161.8K
Jul 6KROS
Keros Therapeutics, Inc.
Prener AnneInsiderOther$0

4 filings